Zhu F, Jin P, Zhu T, Wang W, et al. Safety and immunogenicity of a recombinant adenovirus type-5-vectored COVID-19 vaccine with a homologous prime-boost regimen in healthy participants aged 6 years and above: a randomised, double-blind, placebo-controlled, phase 2b trial. Clin Infect Dis 2021 Sep 22. pii: 6374123. doi: 10.1093.
PMID: 34551104